- Investing Ideas
- /
- Danish Solid Balance Sheet and Fundamentals
Danish Solid Balance Sheet and Fundamentals
Results
5
High return on equity, past performance and sound balance sheet.
5 companies
ChemoMetec
Market Cap: DKK 11.3b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 647.50
7D
-6.6%
1Y
63.3%
Genmab
Market Cap: DKK 127.8b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 2,076.00
7D
-1.1%
1Y
33.6%
Gubra
Market Cap: DKK 6.9b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 419.40
7D
-5.5%
1Y
-3.8%
Zealand Pharma
Market Cap: DKK 34.0b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 483.00
7D
-5.3%
1Y
-38.8%
Dataproces Group
Market Cap: DKK 226.5m
Provides IT and consulting services for municipalities in Denmark.
DATA
DKK 6.60
7D
-4.1%
1Y
20.0%